Market Overview:
The global vancomycin hydrochloride market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of infectious diseases and rising demand for vancomycin hydrochloride from human and animal applications. Based on type, the global vancomycin hydrochloride market is segmented into 99% purity and other. The 99% purity segment is expected to account for a larger share of the market in 2018 owing to its superior quality as compared to other types available in the market. Based on application, the global vancomycin hydrochloride market is segmented into human and animals. The human application segment is expected to account for a larger share of the market in 2018 owing to rising demand for this drug from hospitals and clinics across regions.
Product Definition:
Vancomycin Hydrochloride is an antibiotic that is used to treat a variety of bacterial infections. It works by stopping the growth of bacteria. Vancomycin Hydrochloride is important because it can be used to treat infections that are resistant to other antibiotics.
99% Purity:
99% purity vancomycin hydrochloride is a crystalline form of vancomycin. It has the same basic structure as that of regular Vancomycin but, it has been purified to get rid of any impurities that may be found in the final product.
Other:
Other is used as an alternative to the trade name drug Vancomycin Hydrochloride. Other drugs have been tested for activity against E. coli and found to be ineffective. The reason being, other than Vancomycin, there are no effective antibiotics against E.
Application Insights:
The global vancomycin market is segmented by application into human and animal healthcare. The human segment dominated the overall market in terms of revenue share in 2017, owing to the rising prevalence of multi-drug resistant bacteria including Staphylococcus aureus, coagulase negative staphylococci and Escherichia coli among others. These pathogens are highly susceptible to vancomycin due to its unique cell wall binding properties that help overcome drug resistance.
Animal health accounted for a significant share in 2017 as animals such as cattle, swine and poultry are known reservoirs of several infectious diseases that can be transmitted to humans resulting in food safety issues. In addition, there has been an increase in consumption of animal products including meat from animals treated with antibiotics which increases the risk for humans consuming antibiotic-resistant bacteria through contact with infected livestock or their products like milk & eggs.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The presence of a large number of manufacturers coupled with rising healthcare expenditure and awareness regarding Vancomycin-resistant Staphylococcus aureus (VRSA) has led to high demand for the drug in this region. In addition, increasing prevalence of multi-drug resistant tuberculosis is expected to drive the regional market over the forecast period.
The European region accounted for 24% share in terms of revenue and is anticipated to grow at an estimated CAGR 5.4% from 2018 to 2030 owing primarily to rising incidence rates of vancomycin-resistant enterococci as well as methicillin-resistant Staphylococcus aureus infections which are major applications for Vancomycin hydrochloride tablets marketed by Teva Pharmaceuticals USA, Inc., Sun Pharmaceutical Industries Ltd.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) due to the increasing number of surgeries and other invasive procedures, growing population of elderly and immunocompromised patients, and rising prevalence of antibiotic-resistant bacteria
- Rising demand for vancomycin hydrochloride from emerging markets due to the increasing incidence of HAIs in these regions
- Growing use of vancomycin hydrochloride as a last resort drug for treating serious infections caused by multidrug-resistant bacteria
- Increasing R&D investments by pharmaceutical companies for developing novel antibiotics that can overcome resistance to existing drugs
- Technological advancements that have led to the development of new formulations and delivery methods for vancomycin hydrochloride
Scope Of The Report
Report Attributes
Report Details
Report Title
Vancomycin Hydrochloride Market Research Report
By Type
99% Purity, Other
By Application
Human, Animals
By Companies
Xellia Pharmaceuticals, North China Pharmaceutical Company, Livzon Group Fuzhou Fuxing Pharmaceutical, Zhejiang Medicine, Hisun Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Vancomycin Hydrochloride Market Report Segments:
The global Vancomycin Hydrochloride market is segmented on the basis of:
Types
99% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human, Animals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Xellia Pharmaceuticals
- North China Pharmaceutical Company
- Livzon Group Fuzhou Fuxing Pharmaceutical
- Zhejiang Medicine
- Hisun Pharmaceuticals
Highlights of The Vancomycin Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% Purity
- Other
- By Application:
- Human
- Animals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vancomycin Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vancomycin hydrochloride is a antibiotic that is used to treat bacterial infections. It works by killing the bacteria cells that are causing the infection. Vancomycin hydrochloride is usually taken by mouth, but it can also be given as an injection into a vein.
Some of the major companies in the vancomycin hydrochloride market are Xellia Pharmaceuticals, North China Pharmaceutical Company, Livzon Group Fuzhou Fuxing Pharmaceutical, Zhejiang Medicine, Hisun Pharmaceuticals.
The vancomycin hydrochloride market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vancomycin Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vancomycin Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vancomycin Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vancomycin Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vancomycin Hydrochloride Market Size & Forecast, 2020-2028
4.5.1 Vancomycin Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Vancomycin Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 99% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human
6.2.2 Animals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vancomycin Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vancomycin Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 99% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human
9.10.2 Animals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 99% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human
10.10.2 Animals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 99% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human
11.10.2 Animals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 99% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human
12.10.2 Animals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 99% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human
13.10.2 Animals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vancomycin Hydrochloride Market: Competitive Dashboard
14.2 Global Vancomycin Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Xellia Pharmaceuticals
14.3.2 North China Pharmaceutical Company
14.3.3 Livzon Group Fuzhou Fuxing Pharmaceutical
14.3.4 Zhejiang Medicine
14.3.5 Hisun Pharmaceuticals
